S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CASI CASI Pharmaceuticals Inc

6.41

-0.09 (-1.38%)

Aug 14 2024 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

CASI Pharmaceuticals (NASDAQ:CASI)
Historical Stock Chart
From Jul 2024 to Aug 2024

Click Here for more CASI Pharmaceuticals Charts.

CASI Pharmaceuticals (NASDAQ:CASI)
Historical Stock Chart
From Aug 2023 to Aug 2024

Click Here for more CASI Pharmaceuticals Charts.

CASI Pharmaceuticals Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 14 August 2024 (16 hours ago) • Edgar (US Regulatory)

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
Friday 19 July 2024 (4 weeks ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 19 July 2024 (4 weeks ago) • Edgar (US Regulatory)

Form D - Notice of Exempt Offering of Securities
Monday 15 July 2024 (1 month ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 8 July 2024 (1 month ago) • Edgar (US Regulatory)

CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP
Monday 8 July 2024 (1 month ago) • PR Newswire (US)

CASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the Company
Wednesday 26 June 2024 (2 months ago) • PR Newswire (US)

CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He
Wednesday 26 June 2024 (2 months ago) • PR Newswire (US)

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)
Wednesday 15 May 2024 (3 months ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 15 May 2024 (3 months ago) • Edgar (US Regulatory)

CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTS
Tuesday 14 May 2024 (3 months ago) • PR Newswire (US)

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
Monday 8 April 2024 (4 months ago) • PR Newswire (US)

More CASI Pharmaceuticals Inc News Articles

Progressive Care (QB)

Astra Veda (PK)

Virexit Technologies (PK)

Elite Pharmaceuticals (QB)

Net Savings Link (PK)

Ubiquitech Software (PK)

Kona Gold Beverage (PK)

Digital Brand Media and ... (PK)

TPT Global Tech (PK)

ProText Mobility (PK)

Seafarer Exploration (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions